heart disease
clinical biomarkers Heart failure
pathophysiology of heart failure
comorbidities of heart failure
human heart samples
Integrative omics of heart failure
clinical cases
research program
discovery of novel drug targets
discovery of drug targets
valvular disease
subjects
discovery pipeline
clinical importance of plasma proteins
unique Swedish nation-wide disease registers
novel microarray-based methods
large population-based cohorts
nation-wide Swedish registers
genome-wide discovery of variants
outcomes
risk
New therapeutic targets
Therapy
translational research profile
promise of precision medicine
novel human cardiomyocyte strain assay
large biobanks
genetic variants
proteomic findings
comprehensive plasma protein profiling
underlying causes
expression profiling
multitude of causes
pathophysiological mechanisms
new insights
resequencing
mass spectrometry
epidemiological approach
DNA microarrays
leading cause of morbidity
mortality
experience
investigator
loss of viable
functional muscle cells
endophenotypes
assessment of heritable components
consequences
cardiac structure
genomics
epidemiology
aging European populations
end-stage
work packages
proteomics
generations